JHS SVENDGAARD LABORATORIES LTD. - 532771 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- KIRTI MAHESHWARIDesignation :- Company Secretary and Compliance Officer JHS SVENDGAARD LABORATORIES LTD. - 532771 - Closure of Trading Window
In pursuant to Schedule B to the SEBI (Prohibition of Insider Trading) Regulations 2015, as amended, read with 'Code of Conduct for Prevention of Insider Trading' and 'Code of Conduct for Practices and Procedures Fair Disclosure of Unpublished Price Sensitive Information (UPSI)', the 'Trading Window' of the company shall remain closed for trading in company's securities by Designated Persons, Connected Persons as defined in the aforesaid 'Code of Conducts' and immediate relative thereof from 01st January, 2021 till the end of 48 hours after the declaration of financial results for Quarter ended 31st December, 2020. The date of Board Meeting of the Company for consideration and declaration of the Financial Results for the Quarter ended 31st December, 2020 will be intimated in due course. JHS SVENDGAARD LABORATORIES LTD. - 532771 - Half-Yearly Disclosure On Related Party Transaction For The Period Ended On September 30, 2020
In compliance with regulation 23 (9) of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, please find attached herewith disclosure on Related Party Transaction in the format specified in the applicable Accounting Standards for the half year ended September 30, 2020. JHS SVENDGAARD LABORATORIES LTD. - 532771 - NIL STATEMENT ON DEVIATION OR VARIATION OF FUNDS RAISED THROUGH PREFERENTIAL ISSUE
As per the SEBI Circular No. CIR/CFD/CMD1 /162/2019 dated December 24, 2019, issued by the SEBI titled "Format on Statement of Deviation or Variation for proceeds of public issue, rights issue, preferential issue, Qualified Institutions Placement (QIP) etc." and pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith is a Nil statement issued by the Company on the captioned subject. JHS SVENDGAARD LABORATORIES LTD. - 532771 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
Press Release Revised released originally on 03rd November, 2020 Commenting on the results, Mr. Nikhil Nanda, Managing Director (JHS), said, 'Your Company has regained the growth momentum in the current quarter that was disrupted for a short while in the previous quarter due to the overall economic slowdown caused by the pandemic. We have rather came out much stronger with improved operating profitability by ~ 1500 basis points {EBIDTA Margin Q2, FY 20-21: 11.42%, Q1, FY 20-21: (3.55%)}. The company has added one new private label client and has also successfully completed the commercial trials, with now being listed as supplier to one of the largest consumer products company in the world during the quarter ending 30th September, 2020. The company has also done rationalization in its expenditures to improve the operating margins. JHS SVENDGAARD LABORATORIES LTD. - 532771 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Hereby Enclosed are the copies of newspapers publications in which Unaudited Standalone and Consolidated Financial Results for the Second Quarter & Half year ended September 30, 2020 are published on November 05, 2020 in Business Standard (English) and Business Standard (Hindi). JHS SVENDGAARD LABORATORIES LTD. - 532771 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
JHS Svendgaard Laboratories Limited announces consolidated Q2 FY 20-21 results, Consolidated revenue grows to Rs.32.11 crore. JHS Svendgaard Laboratories Ltd. (JHS) one of India's leading Oral-care manufacturing company reported its financial results for the first quarter ending 30th September, 2020. JHS SVENDGAARD LABORATORIES LTD. - 532771 - Outcome Of Board Meeting Held On November 03, 2020 And Un-Audited Financial Results (Standalone & Consolidated) For The Quarter & Half Year Ended September 30, 2020 With Limited Review Reports Thereon
Pursuant to Regulation 30 and 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of JHS SVENDGAARD LABORATORIES LTD ('the Company'), at their meeting held today, i.e. on November 03, 2020 (commenced at [12:00] PM and concluded at [03:45] PM), has, inter- alia, approved the Standalone & Consolidated Un-Audited Financial Results (UFRs) for the quarter & half year ended on September 30, 2020 and taken on record the Limited Review Reports (LRRs) on such UFRs. Copies of duly such signed UFRs (Standalone and Consolidated) for the quarter & half year ended on September 30, 2020 along with the LRRs thereon are enclosed herewith. Further, the aforesaid information is also being made available on the website of the Company at www.svendgaard.com. JHS SVENDGAARD LABORATORIES LTD. - 532771 - Outcome Of Board Meeting Held On November 03, 2020 And Un-Audited Financial Results (Standalone & Consolidated) For The Quarter & Half Year Ended September 30, 2020 With Limited Review Reports Thereon
Pursuant to Regulation 30 and 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of JHS SVENDGAARD LABORATORIES LTD ('the Company'), at their meeting held today, i.e. on November 03, 2020 (commenced at [12:00] PM and concluded at [03:45 ] PM), has, inter- alia, approved the Standalone & Consolidated Un-Audited Financial Results (UFRs) for the quarter & half year ended on September 30, 2020 and taken on record the Limited Review Reports (LRRs) on such UFRs. Copies of duly such signed UFRs (Standalone and Consolidated) for the quarter & half year ended on September 30, 2020 along with the LRRs thereon are enclosed herewith. Further, the aforesaid information is also being made available on the website of the Company at www.svendgaard.com. JHS SVENDGAARD LABORATORIES LTD. - 532771 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation of our letter dated October 27, 2020 we enclose copies of the advertisements published on October 28, 2020, in Business Standard (English) and Business Standard (Hindi) with respect to the Notice of the Board Meeting scheduled to be held on 03rd November, 2020.